Protecting African patients through zero-defect pharmaceutical AI.
Beyond unlocking hundreds of millions of Naira in trapped working capital for domestic drug manufacturers, BioKinetyc safeguards public health across West Africa. By automating pharmacopeia-grade HPLC and optical quality control, we prevent substandard batches from ever leaving the factory gate while empowering African clinical researchers to lead global trials.
100% interception of off-spec dissolution, impurity drift, and vial particulate deviations prior to release.
Nigerian QC analytical chemists, pharmacists, and clinical trial coordinators equipped with AI telemetry.
Antimalarials, pediatric antibiotics, and sterile parenterals verified by AssayVision™ across Nigeria.
TrialEscrow™ eliminates the 90-day reimbursement lag that historically crippled local teaching hospital trials.
How algorithmic GMP elevates African healthcare.
Eliminating Substandard API Potency & Thermal Degradation Before Distribution
In tropical Climatic Zone IVb environments, active pharmaceutical ingredients degrade rapidly if excipient moisture or enteric coating integrity is compromised. Manual random sampling inspects less than 0.5% of tablet output, allowing defective blisters to reach hospital pharmacies.
Bringing Global Phase II–IV Clinical Trials to Nigerian Teaching Hospitals
Although Africa bears over 24% of the global disease burden, less than 3% of global clinical trials are conducted on the continent—largely because international sponsors fear slow paper CRF data collection and opaque grant accounting.
Accelerating WHO-GMP Prequalification & AfCFTA Medicine Exports
West Africa imports over 70% of its finished pharmaceuticals. For Nigerian CMOs to unlock international donor procurement (UNICEF, Global Fund) and export across ECOWAS, they must demonstrate unimpeachable 21 CFR Part 11 and WHO-GMP Annex 11 data integrity.
Direct feedback from Nigerian life-sciences leaders.
Pharm. Adaeze Nwosu, M.Pharm
Head of Analytical Quality Control · Agbara Industrial Estate
“Before BioKinetyc, our analytical chemists spent nights manually integrating HPLC peaks and typing COA tables into Word—a single typo could delay batch release by a week. With AssayVision™ connected to our Waters Empower servers, secondary impurity peaks are flagged in milliseconds and our Qualified Person releases batches in 6 hours.”
Prof. Babatunde Ogunleye, MBBS, FWACP
Principal Clinical Investigator · Abuja & Ibadan Trial Corridor
“Coordinating multi-center infectious disease trials across five Nigerian teaching hospitals used to suffer from 60-day site grant delays and inconsistent adverse-event coding. VigilanceSentinel™ standardized our MedDRA coding to 99.8% concordance, and TrialEscrow™ pays our site coordinators the same hour patient follow-up locks.”
Our 2028 scale & bio-security commitments.
Scaling autonomous GMP quality control and clinical trial infrastructure across Nigeria, Ghana, Kenya, Senegal, and Rwanda.
100M+ Patient Doses Audited
Deploying inline AssayVision™ optical and spectral inspection across 65+ African GMP pharmaceutical plants to eradicate substandard essential medicines.
50,000+ Trial Participants
Supporting 120+ multi-center Phase II–IV clinical trials across African teaching hospitals with real-time VigilanceSentinel™ safety monitoring.
15 WHO-Prequalified Plants
Guiding West and East African contract manufacturers to full WHO-GMP Annex 11 and FDA 21 CFR Part 11 prequalification via DossierLex™.
Partner with an operating system that protects patient lives & plant yields.
Join the 21 pharmaceutical manufacturers, analytical QC labs, and CROs operating 3,400+ active protocols on BioKinetyc.